Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,791 | 5,354 | 5,139 | 1,076 | N/A |
| Marketable Securities | 12 | 154 | N/A | N/A | N/A |
| Receivables | 349 | 516 | 102 | 1,072 | N/A |
| Inventories | 888 | 814 | 202 | 138 | N/A |
| Other current assets | 0 | 334 | 1,022 | 0 | 0 |
| TOTAL | $5,040 | $7,172 | $6,465 | $2,286 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,329 | 1,407 | 1,033 | 1,136 | N/A |
| Other Non-Current Assets | 3,383 | 173 | 591 | 668 | 0 |
| TOTAL | $5,712 | $1,580 | $1,624 | $1,804 | $N/A |
| Total Assets | $10,752 | $8,752 | $8,089 | $4,090 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24 | 22 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 833 | 622 | 1,419 | 1,929 | 0 |
| Accrued Expenses | 1,203 | 619 | N/A | N/A | N/A |
| Other current liabilities | N/A | 970 | N/A | N/A | N/A |
| TOTAL | $3,457 | $2,233 | $1,419 | $1,929 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 22 | 3,663 | 81 | N/A |
| Deferred Revenues | 942 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,207 | 1,077 | 386 | 618 | 0 |
| TOTAL | $3,207 | $1,099 | $4,049 | $699 | $N/A |
| Total Liabilities | $6,664 | $3,332 | $5,468 | $2,628 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2,368 | 1,580 | 1,442 | 909 | N/A |
| Retained earnings | -67,260 | -56,096 | -50,297 | -44,747 | N/A |
| Other shareholders' equity | -969 | -969 | 0 | 0 | 0 |
| TOTAL | $4,088 | $5,420 | $2,621 | $1,462 | $N/A |
| Total Liabilities And Equity | $10,752 | $8,752 | $8,089 | $4,090 | $0 |